Merck‚ the FDA‚ and the VIOXX Recall MBA 520-D4C2 Ethics & Leadership in a Global Environment April 22‚ 2012 Merck and Vioxx Recall Did Merck act in social and ethical manner? In 2005‚ Merck was ranked fourth in sales among pharmaceutical companies. Merck had released the drug Vioxx‚ for treating Osteoarthritis in late 1990. Merck as a company has a reputation of being one of the most ethical and
Premium Marketing Brand Management
CASE 5.1: MERCK ACQUISITION OF MEDCO Abstract Corporate mergers and acquisitions (M&A) have become popular across the globe during the last two decades due to globalization‚ liberalization‚ technological developments‚ and competitive business environment (Fisher & Siburg‚ 2009). The synergistic gains from M&A may result from efficient management‚ economies of scale‚ profitable use of assets‚ exploitation of market power‚ and the use of complementary resources (Mitchell
Premium Pharmacology Pharmaceutical industry Pharmacy
agency problems on the cost of capital Tung-Hsiao Yang* Current Version: September 10‚ 2008 * Assistant Professor of Finance‚ National Chung Hsing University‚ Department of Finance‚ No. 250‚ Kuo Kuang Rd.‚ Taichung 40227‚ Taiwan‚ tyang1@nchu.edu.tw. The author thanks National Science Council for financial support in this project‚ NSC96-2416-H-005-026. The Impact of two agency problems on the cost of capital Abstract We test the relation between the cost of capital and two agency problems
Premium Rate of return Cash flow Principal-agent problem
A Discussion on the Company’s Decision Making Process‚ Group Behavior and Organizational Structure Abstract Merck is a pharmaceutical and medical researching company that is dealing with managerial challenges in their daily business operations. Their background and their issues regarding the matter will then help one understand how the actual picture of the real accounts of the managerial decision processes that happen to actual multinational company operations. Having been
Premium Corporation Business Company
CHAPTER 10 Return and Risk: The Capital Asset Pricing Model (CAPM) Multiple Choice Questions I. DEFINITIONS PORTFOLIOS a 1. A portfolio is: a. a group of assets‚ such as stocks and bonds‚ held as a collective unit by an investor. b. the expected return on a risky asset. c. the expected return on a collection of risky assets. d. the variance of returns for a risky asset. e. the standard deviation of returns for a collection of risky assets. Difficulty level: Easy PORTFOLIO WEIGHTS
Premium
3rd‚ 2014 Case 5: Merck‚ the FDA‚ and the Vioxx Recall Section I Merck was one of the world’s leading pharmaceutical firms. The company ranked 4th I sales after Pfizer and Johnson & Johnson and it ranked 5th in assets and market value. Merck ranked 1st in profits‚ earning $7.33 billion on $30.78 billion in sales. In 2006‚ Merck faced major challenges with their once best selling prescription painkillers‚ Vioxx which was pulled off the market in September of 2004 after Merck learned it increased
Free Pharmacology Food and Drug Administration
JOURNAL OF FINANCE • VOL. LIII‚ NO. 4 • AUGUST 1998 Agency Costs‚ Risk Management‚ and Capital Structure HAYNE E. LELAND* ABSTRACT The joint determination of capital structure and investment risk is examined. Optimal capital structure ref lects both the tax advantages of debt less default costs ~Modigliani and Miller ~1958‚ 1963!!‚ and the agency costs resulting from asset substitution ~Jensen and Meckling ~1976!!. Agency costs restrict leverage and debt maturity and increase yield spreads
Premium Capital structure Corporate finance Debt
Prescription Drug Costs Should Medicare be allowed to negotiate drug prices? Is the debate in this case Americans on Medicare have out-of-pocket spending tends that increase with age; in 2010‚ beneficiaries ages 85 and older spent three times more out-of-pocket on services‚ on average more than beneficiaries ages 65 to 74 ($5‚962 vs. $1‚926). With prescription drug costs out of control since the Patient Protection and Affordable Care Act (PPACA)‚ commonly called the Affordable Care Act (ACA) drug cost
Premium Health care Medicine Health insurance
Financial Decision Analysis~Marriott Corporation Case Study Executive Summary – Q5 – Hurdle Rate Analysis Hurdle rates‚ the weighted cost of capital that projected cash flows must exceed for initiatives to be considered‚ vary within Marriott Corporations due to their unique industry risk levels and capital structures. They use this number to determine which projects to accept‚ to adjust the rate at which the firm grows and as a measure for compensation within each business area‚ and as incentive
Premium Weighted average cost of capital Finance
10/6/2014 Case 3: Merck and River Blindness 1. Why was Merck hesitant about developing a human version of Ivermectin? Merck considered this opportunity as a high risk investment. The cost of developing the drug was estimated at $100 million. Even if it was successful to cure river blindness the victims were too poor to afford the drug. There was no way to distribute it in these rural areas were the victims were located. In addition‚ there was a possibility that people would misuse the drugs‚ which would
Premium Onchocerciasis Human